+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evaluation of kits for the detection of fibrin(ogen) degradation products in dogs



Evaluation of kits for the detection of fibrin(ogen) degradation products in dogs



Journal of Veterinary Internal Medicine 13(5): 478-484



The sensitivities and specificities of 3 commercial serum fibrin(ogen) degradation product (FDP) kits and one plasma FDP kit for the detection of FDPs in dogs were determined. Blood was collected for measurement of serum and plasma FDP concentrations from 30 healthy dogs and from 20 dogs that fulfilled clinical and laboratory criteria for disseminated intravascular coagulation.

(PDF emailed within 0-6 h: $19.90)

Accession: 003438748

Download citation: RISBibTeXText

PMID: 10499733

DOI: 10.1111/j.1939-1676.1999.tb01466.x


Related references

Evaluation of latex agglutination kits for detection of fibrin(ogen) degradation products and D-dimer in healthy horses and horses with severe colic. Veterinary Clinical Pathology 34(4): 375-382, 2005

Serum and plasma latex agglutination tests for detection of fibrin(ogen) degradation products in clinically III dogs. Veterinary Clinical Pathology 30(3): 133-136, 2001

Detection of fibrin(ogen) degradation products by a latex clumping method. Scandinavian Journal of Haematology. Supplementum 13: 115-119, 1971

The latex flocculation inhibition test for the detection of fibrin(ogen) degradation products. Scandinavian Journal of Haematology. Supplementum 13: 389-390, 1971

Soluble fibrin (ethanol gelation test) and fibrin(ogen) degradation products in suspected thrombosis with reference to the 125I-fibrinogen uptake test for detection of thrombus formation. European Journal of Haematology 31(S39): 65-74, 1983

A comparative evaluation of ELISAs for D-dimer and related fibrin(ogen) degradation products. Blood Coagulation & Fibrinolysis 4(4): 537-549, 1993

Use of monoclonal antibodies to fibrinogen, fibrin and fibrin (ogen) degradation products in atherosclerosis. NATO ASI series Series A Life sciences19(219): 189-197, 1991

The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemporary Oncology 17(2): 113-119, 2013

Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 9(1): 109-121, 1989

Content of soluble fibrin monomeric complexes, factor XIII and fibrin(ogen) degradation products in neonatal asphyxia. Archives of Gynecology 228(1-4): 626-627, 1979

A diagnostic-prognostic test for bladder cancer using a monoclonal antibody-based enzyme-linked immunoassay for detection of urinary fibrin(ogen) degradation products. Cancer Research 44(12 Pt 1): 5886-5893, 1984

Ca binding of rat fibrinogen and fibrin(ogen) degradation products. Febs Letters 93(1): 177-180, 1978

The fibrin(ogen) degradation products and platelets in meningococcal infection. Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 9(4): 887-892, 1973

Calcium-binding properties of human fibrin(ogen) and degradation products. Febs Letters 98(2): 257-259, 1979

Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats. Thrombosis and Haemostasis 48(1): 59-61, 1982